Search Within

Jedd D Wolchok

  1. "James Allison"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (14)
  3. Book Section (2)
Groups
  1. Department of Medicine (32)
  2. GSK Faculty (32)
  3. Melanoma and Immunotherapeutics Service (32)
  4. Solid Tumor Oncology Division (32)
  5. Department of Pathology and Laboratory Medicine (12)
  6. Biostatistics Service (11)

More Groups

People
  1. James Allison (32)
  2. Jianda Yuan (20)
  3. Humilidad Gallardo (10)
  4. Lloyd Old (8)
  5. Teresa Rasalan (8)
  6. Yinyan Xu (8)

More People

Years
  1. 2014 (3)
  2. 2013 (7)
  3. 2012 (3)
  4. 2011 (6)
  5. 2010 (5)
  6. 2009 (5)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer Research (3)
  3. Cancer Immunity (2)
  4. Journal of Immunotherapy (2)
  5. Proceedings of the National Academy of Sciences of the United States of America (2)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (4)
  3. Academy of Cancer Immunology (2)
  4. Biomed Central Ltd (2)
  5. Lippincott Williams & Wilkins (2)
  6. National Academy of Sciences (2)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus
    Meeting Abstract

    Zamarin, D.; Holmgaard, R. B.; Subudhi, S. K.; Park, J. S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilinournab (ipi)
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J. D.; Dong, Z. W.; Emerson, R.; Robins, H.; Redmond, D.; Zhao, C. J.; Mu, Z. Y.; Wong, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Mcarthur, H. L.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • A pilot study of preoperative, single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Sung, J. S.; Blum, B.; Neville, D. A.; Kotin, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study of pre-operative (Pre-op), single-dose ipilimumab (Ipi) andlor cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J.; Blum, B.; Yuan, J.; Patil, S.; Neville, D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Immune co-signaling to treat cancer
    Book Section

    Callahan, M. K.; Wolchok, J. D.; Allison, J. P.; Sharma, P.
    In Curiel, T. J. (Eds.) Cancer Immunotherapy: Paradigms, Practice and Promise (2013)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; Neville, D. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase and T-cell based anti-tumor immunotherapies targeting immune checkpoints
    Meeting Abstract

    Holmgaard, R.; Zamarin, D.; Munn, D.; Wolchok, J.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save